Presentation on Top line phase 1 trials followed by next steps...

Presentation on Top line phase 1 trials followed by next steps for phase 1 program and pipeline expansion. If trial results were bad, don't think we would have an entire investor presentation lined up to announce them lol....not to mention an announcement about the next step for the phase 1 program which seems to imply progress.. and progress implies a successful phase 1 has been achieved. When biotechs have bad results to report....what you usuallyy get is a delayed trading halt followed up by the results. Adalta are instead organising an investor presentation for the results. Confidence is high and it is my opinion.. phase 1 was successful. This one is for the long haul.. give Adalta their time to finish up all phases of clinical trials...if they are positive then we will be trading at a Dollar by then anyways. Things are looking good...when volume starts flowing into the stock then there is only one direction the price can go.